Follow Our Journey.
Partner With Us
Our Reach.
Incredible Science. Unequal Access.
Although dozens of cell and gene therapies are in development or already approved, the overwhelming majority of patients remain excluded because of cost, infrastructure and geography. Most low- and middle-income countries have been left out of the clinical development pipeline.
0
M
people living with HIV worldwide
0
%
of people living with HIV and SCD live in Africa
0
k+
children born with sickle cell disease annually
0
%
or fewer eligible patients have access to gene therapy
0
The number of cell and gene therapy trials for sickle cell or HIV which have taken place around the world
0
The number of cell and gene therapy trials for sickle cell or HIV which have taken place in Africa